Medifast Inc

Medifast Inc

MED

Get informed when a big investor buys or sells

+ Follow
Market Cap$116.86M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medifast IncMedifast Inc-5.8--10%0.40.1
$41.67

Current Fair Value

280.2% upside

Undervalued by 280.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$116.86 Million
Enterprise Value$61.43 Million
Dividend Yield$- (-)
Earnings per Share$-1.7
Beta0.66
Outstanding Shares11,006,000

Return

Return on Equity-10.13%ROE
Return on Assets-7.94%
Return on Invested Capital-6.69%

Valuation & Multiples

P/E Ratio-5.77P/E Ratio
PEG-3.3PEG
Price to Sales0.35Price to Sales
Price to Book Ratio0.64Price to Book Ratio
Enterprise Value to Revenue0.18
Enterprise Value to EBIT-4.37
Enterprise Value to Net Income-4
Total Debt to Enterprise0.26
Debt to Equity0.08Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 4, 2026
EPS Estimate
$-0.55
Average shareholder expectation
Revenue Estimate
$69.20 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 3, 2026
EPS Estimate
$-0.68
Average shareholder expectation
Revenue Estimate
$72.70 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0351 4.70%
Total Calls1,598,300 53.83%
Total Puts56,100 34.23%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %78.34% 4.96%
Total Invested$87.64M 1.30%
Investors Holding120 6.00%

ESG Score

No data

About Medifast Inc

550 employees
CEO: Daniel Chard

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...